News Hub | News Direct

Lifestyle

Beverage: Coffee/Tea/Non-Alcoholic Beverage: Spirits/Beer/Wine Casino/Gaming Fashion Food/Cooking/Baking Health & Fitness Home Goods Hospitality Leisure Activities & Hobbies Parenting Pets Photography Seniors Travel & Tourism
Article thumbnail News Release

VOESH New York Launches New 28 oz. Vegan Hand & Body Crème Collection

VOESH New York

VOESH New York is debuting a new 28 oz. Vegan Hand & Body Crème Collection, created to provide salon clients with a luxurious and healthier hydration experience. These larger bottles offer the same high-quality, vegan-friendly ingredients that have established VOESH as a leader in the body care industry. “We’re thrilled about the addition of these generously sized lotions to VOESH’s product line,” said Tom Harrison, Principal of Coleman Harrison. “VOESH consistently outshines the competition with expert formulas. This new size will undoubtedly enhance manicure and pedicure services, delivering superior results for both clients and technicians.” “As a bonus, technicians can pair these lotions with VOESH’s best-selling Pedi in a Box products,” added Kendall Stone, Principal of Jay Stone Sales. Enriched with 94+% natural-origin ingredients, VOESH’s 28 oz. crèmes are formulated with organic virgin olive oil and natural extracts. They are infused with 100% vegan, clean, and certified organic components and are free from parabens, phthalates, gluten, mineral oil, and more than 1,680 other potentially harmful substances. The velvety texture provides long-lasting moisture and a radiant glow without a greasy feel. These larger bottles not only provide a superior experience but also ensure lasting hydration and value. “Our lotions have always been a best-seller, so we’ve brought them back in a more convenient size for salons,” said Joseph Choi, Co-Founder of VOESH New York. “Salon owners have been asking for our popular massage butter in a bottle, and we’re ecstatic to fulfill this request.” The new collection is available in five delightful scents: Olive Sensation, Lavender Relieve, Vitamin Recharge, Jasmine Soothe, and Green Tea Detox. Each scent is made with premium, IFRA-certified fragrances that pair perfectly with VOESH’s best-selling Pedi in a Box Deluxe 4 Step pedicure kits. This allows for a cohesive pampering experience that caters to clients’ preferences. With a transparent ingredient list, dermatologist testing, and U.S. FDA registration, VOESH’s new 28 oz. Vegan Hand & Body Crèmes are the best addition to guarantee clients and technicians feel good about what goes on their skin. For more information about VOESH’s new 28 oz. Vegan Hand & Body Crèmes, please visit voeshpro.com. About VOESH New York: Founded in 2013, VOESH New York has emerged as a premier destination for clean and efficacious body care solutions catering to head-to-toe wellness. Noteworthy products include Pedi in a Box, Mani in a Box, the award-winning Shower & Empower Vitamin C Shower Filter, and Collagen Gloves and Socks. VOESH New York is committed to providing 100% vegan, cruelty-free, and sustainable products because every body deserves better beauty! All VOESH New York products are certified by PETA and registered with the US Mocra, EU CPNP and UK SCPN, maintaining vegan, cruelty-free, and dermatologist-tested standards. VOESH New York proudly excludes all 1,680+ EU-banned ingredients and an additional 400+ potentially harmful ingredients. For more information, visit VOESH New York’s website at Voesh.com or contact press@voesh.com. All VOESH New York products are certified by PETA and registered with the EU CPNP, and UK SCPN. Always vegan, cruelty-free, and dermatologist-tested, VOESH New York proudly excludes all 1,680+ EU-banned ingredients and an additional 400+ potentially harmful ingredients. Contact Details Colleen Mathis +1 917-690-5560 Colleen@absoluterrelations.com Company Website https://voesh.com/

September 06, 2024 08:00 AM Eastern Daylight Time

Article thumbnail News Release

Top U.S. Sportsbooks Lost Out on $160.7 Million in Handle Last NFL Season, According to Latest Report from Sports Odds Intelligence Firm Bettormetrics

Bettormetrics

Bettormetrics, a sports odds intelligence firm providing competitive sports odds data and insight to the sports betting industry, released their latest report on the 2023-2024 NFL season today. The analysis found four out of the five top sportsbooks in the U.S. potentially lost over $160.7 million of revenue last NFL season due to extended suspension times and poor pricing strategies. Bettormetrics’ analysis of last season’s NFL games found that BetMGM and Bet365 were suspended in-game and not taking live wagers on average 5-10% more each game than the market leaders. Suspension is when a sportsbook periodically shuts down betting lines in a sporting event to readjust the odds based on activity within the event, while uptime is the amount of time they are accepting live wagers during the game. DraftKings averaged 96.1% uptime last season, while Bet365 averaged only 85.5% uptime – leading to a potential loss of $4.6 million. With the American Gaming Association estimating that betting on the NFL will surge by 30% in 2024 to $35 billion, this means that over $220 million will potentially be lost by tier 1 operators over the coming season. “DraftKings is clearly the team to beat when it comes to NFL betting,” said Robert Urwin, Bettormetrics’ co-founder and CEO. “With the most amount of uptime during NFL games and least amount of time suspended in isolation compared to the other bookmakers, DraftKings has a grip on the most critical betting season in the U.S. FanDuel is close behind and could make up the distance with a few tweaks in their suspension and trading strategies.” Bettormetrics’ Trading Analytics Platform (TAP) aggregates trading performance data so bookmakers gain insight into the performance of their competitors and their own trading desk, and in turn make changes to increase revenues and profitability. “It’s staggering to see the difference in uptime and therefore potential lost revenue between four of the top sportsbooks leaders in the U.S.,” said Sabin Brooks, Bettormetrics’ Chief Revenue Officer. “Without the proper suspension strategy, it’s extremely difficult for BetMGM and Bet365 to begin to catch up to FanDuel and DraftKings. As we begin the 2024-2025 NFL season, there is a real opportunity to close some of the gap if those two bookmakers can optimize their uptime and trading performance.” Bettormetrics is an innovative company providing competitive sports odds intelligence and insight to the sports betting industry. Bettormetrics’s Trading Analytics Platform is a SAAS product supporting sportsbook trading desks with cutting edge insight and analysis on the entire event life cycle, helping sportsbooks, data suppliers and B2B platforms gain an edge on competitors and ensure no profits are left on the table. For more information, please email info@bettormetrics.com or visit Bettormetrics.com. Contact Details Bailey Irelan birelan@hotpaperlantern.com Company Website https://bettormetrics.com/

September 05, 2024 10:59 AM Eastern Daylight Time

Image
Article thumbnail News Release

Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform

Benzinga

By Anthony Termini, Benzinga Since Covid-19, telemedicine has been expanding significantly, with 44% of physicians using it at least weekly and 40% daily in the U.S. in 2023. The industry is seen by some as a new frontier for patient education and access to medicine and care. The DEA Opens The Digital Door To The Telemedicine Industry Before the pandemic, the primary way a patient would get a drug prescription was through an in-person visit with a doctor. The Drug Enforcement Agency (DEA) loosened those restrictions, allowing physicians to prescribe “controlled medications” over the phone and via video conference. That’s been good for companies in the direct-to-consumer telehealth industry. One of the players in this business is MangoRx or Mangoceuticals, Inc. (NASDAQ: MGRX), which develops a variety of men's health and wellness products and services. Working with Surescripts, which helps coordinate all the parties in the prescription process, MangoRx recently transitioned its telemedicine platform to a newly developed DEA-approved telemedicine operating system. The new system allows MangoRx’s third-party doctor network to prescribe and offer controlled substances. These include Prime Protocol by MangoRx, powered by Kyzatrex, an Oral Testosterone Replacement Therapy and other hormone replacement treatments. According to Jacob Cohen, CEO and co-founder of MangoRx, the company is dedicated to “revolutionizing patient care,” and the new system enhances patient management by “offering seamless doctor visits, prescription auto-refills, and overall health management.” MangoRx is joined in the telehealth space by companies like Hims & Hers Health (NYSE: HIMS), a San Francisco-based telehealth company; Maximus Tribe, a compound pharmaceuticals company that also offers coaching and is based in Santa Monica, California; and Nu Image Medical, a Tampa, Florida-based company that sells weight loss, hormone replacement, sexual health, and general wellness products. Cohen argues, however, that MangoRx is setting a new benchmark for excellence in telemedicine. The company believes that the steps it is taking create meaningful competitive advantages over other companies in the space. MangoRx’s Digital Leap Shortens Time To Market MangoRx, which currently offers therapy options for erectile dysfunction, hair growth and hormone replacement, intends to use the new operating system to roll out new weight loss treatment options. These include an oral dissolvable GLP-1 tablet that includes Semaglutide and Tirzepatide, the ingredients in some of the most popular prescription weight loss medicines. The company’s new operating system helps it accelerate the ability to introduce other new product lines, the first of which is the dissolvable tablet they have branded as Slim and Trim. This brand will help MangoRx capitalize on the significant demand for GLP-1 weight loss treatments for both men and women. MangoRx expects these products will be available to patients before the end of the third quarter and that this new addition will help it to substantially grow revenue moving forward. The company says its new operating system will enable it to respond quickly to market needs and marks an important milestone for MangoRx, representing a significant advancement in its capabilities. Amanda Hammer, COO of MangoRx, says that the company has a “commitment to regulatory compliance and innovation” and that the new operating system’s cutting-edge technology puts it in a position to continue “revolutionizing patient care in the telemedicine industry.” MangoRx notes that the system is fully HIPAA-compliant to ensure that all operations adhere to stringent regulatory standards. The new system includes robust security measures to protect patient data and maintain the highest levels of confidentiality. The system upgrade accompanies a redesigned website with an improved user interface to optimize the customer experience and enhance workflows. The combination creates real-time data tracking and seamless integration that enhance operational efficiency and improve patient engagement. Featured photo by LinkedIn Sales Solutions on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

September 05, 2024 08:50 AM Eastern Daylight Time

Image
Article thumbnail News Release

Get Ready for Free Spins with UnlimitedFreeSpins.com (Exclusive Early Access for Kiwis!)

Acroud Media

Get ready to saddle up because UnlimitedFreeSpins.com is moseyin' on into New Zealand! This fresh platform's all about giving you Kiwis endless free spins on a bunch of wicked slot games, starting with the exclusive pre-launch of Western Reels! Why UnlimitedFreeSpins.com: Free Spins Galore: Just like the name says, you get unlimited chances to spin those reels for free on heaps of different slots. We're talking top-notch entertainment without ever reaching for your wallet. Sweet! Fresh and Flash Slot Games: We haven’t got time for dusty old slots. We're all about bringing you the hottest new releases, like the exclusive Western Reels, that'll have you yellin' "Crikey!" with excitement. No Cost to Play: You can play these top-notch slots without spending a dime. It's all about having a good time and winning' big, thanks to those free spins. Made for Kiwis: We're all about giving our Kiwi mates the best. Every game, promotion, and offer is designed for you, so you know it's safe, legal, and heaps of fun. A New Dawn for Slot Games in New Zealand UnlimitedFreeSpins.com is here to change the game for Kiwi slot players. We're talking about a dedicated platform with endless free spins and fresh new games to explore. Whether you're a seasoned pro or just starting out, this is the place to be. "We're rewriting the rules of online slots," says Sarah Lunness of UnlimitedFreeSpins.com. "It's all about the best gaming experiences without the cost. With the exclusive pre-launch of 'Western Reels,' our Kiwi players get a sneak peek at a game that'll blow your socks off." About UnlimitedFreeSpins.com We're a Kiwi-born online platform dedicated to giving you endless free spins on the latest and greatest slot games. Launched in 2024, we're all about bringing you innovative games and exclusive access to new titles like Western Reels. We're committed to transparency, fun, and responsible gaming, making us the top spot for free spins in New Zealand. Head over to unlimitedfreespins.com to learn more! Contact Details Acroud Media info-media@acroudmedia.com

September 05, 2024 02:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

UnlimitedFreeSpins.com: Exclusive Pre-Launch Access to New Slot Game, Western Reels, for Canadian Players

Acroud Media

Canadian online casino enthusiasts have a new reason to get excited with the launch of UnlimitedFreeSpins.com. This fresh and innovative platform is designed to provide players with unlimited free spins on a wide range of exciting and carefully selected slot games. To mark its launch, UnlimitedFreeSpins.com is offering exclusive pre-launch access to the highly anticipated slot game, Western Reels. Exclusive Pre-Launch Access to Western Reels As part of its commitment to delivering fresh and innovative content, UnlimitedFreeSpins.com is thrilled to offer Canadian players early access to Western Reels, a new slot game that takes players on an exciting journey through the Wild West. With stunning graphics, engaging gameplay, and the chance to win big, Western Reels is set to become a favourite among Canadian players. At UnlimitedFreeSpins.com, we’re focused on bringing our users the latest and greatest in slot gaming, said Lauren Lister of UnlimitedFreeSpins.com. "By offering exclusive pre-launch access to 'Western Reels,' we’re giving our players a unique opportunity to experience this fantastic game before anyone else." What Makes UnlimitedFreeSpins.com Stand Out? ✅ Unlimited Free Spins: As the name suggests, UnlimitedFreeSpins.com is all about providing players with unlimited opportunities to enjoy free spins on a variety of slot games. Each game is selected for its entertainment value, ensuring that players always have something new and exciting to explore. ✅ Innovative Slot Games: The platform focuses on offering fresh and innovative slot games that stand out from the crowd. Whether it’s the exclusive pre-launch of Western Reels or other exciting titles, UnlimitedFreeSpins.com ensures that players have access to the best new games on the market. ✅ No Cost to Play: One of the key features of UnlimitedFreeSpins.com is that players can enjoy these top-tier slot games without spending a dime. The site is designed to provide the best entertainment and the chance to win big, all through free spins. ✅ Tailored for Canadian Players: UnlimitedFreeSpins.com is dedicated to the Canadian market, ensuring that all games, promotions, and offers are fully accessible to Canadian players. This focus on the local market means that players can enjoy a safe, legal, and highly enjoyable gaming experience. A New Era of Slot Gaming in Canada With the launch of UnlimitedFreeSpins.com, Canadian players now have a dedicated platform where they can discover and enjoy the best slot games, complete with unlimited free spins. The platform’s unique approach to gaming ensures that there’s always something new to explore, making it the perfect destination for both new and seasoned players. "We’re redefining what it means to play slots online," added Lauren. "UnlimitedFreeSpins.com is all about delivering the best gaming experiences without the cost. With exclusive pre-launch access to 'Western Reels,' our users get a first look at a game that we believe will set the standard for online slots." About UnlimitedFreeSpins.com UnlimitedFreeSpins.com is a Canadian-based online platform dedicated to providing players with unlimited free spins on the latest and most exciting slot games. Launched in 2024, the site focuses on offering innovative games and exclusive access to new titles like Western Reels. With a commitment to transparency, fun, and responsible gaming, UnlimitedFreeSpins.com is set to become the premier destination for free spins in Canada. For more information, visit https://unlimitedfreespins.com Contact Details Acroud Media info-media@acroudmedia.com

September 05, 2024 01:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

Join Travis Kelce for the Second Annual "Kelce Car Jam" - A Celebration of Cars, Community, and Youth Empowerment.

Full Scope PR

Gear up for an exhilarating evening filled with cars, community, and camaraderie at the 2nd Annual Kelce Car Jam taking place on Saturday, October 5, 2024, from 5-8pm CT. This year’s event, held on Walnut Street in downtown Kansas City, promises to be a thrilling block party that perfectly sets the stage for the Chiefs' Monday Night Football game. Join three-time Super Bowl champion Travis Kelce and his Kansas City Chief teammates as they showcase some of the city’s coolest vintage and luxury cars, including select vehicles from their personal collections. This vibrant event is not just a car show; it's a celebration of community spirit, designed to bring together fans from all walks of life. Adding to the excitement, the talented kids from Operation Breakthrough Ignition Lab will be joining us to show off some of their automotive work. Operation Breakthrough's Ignition Lab is a state-of-the-art STEM workspace that Travis Kelce helped open and has significantly supported. This lab is designed to provide real-world learning opportunities in STEM for high school students, preparing them for future careers and life. They'll present their impressive automotive projects and offer a taste of culinary delight from their newly refurbished food truck. This initiative, supported by the Eighty-Seven & Running Foundation, underscores Travis Kelce’s commitment to empowering youth through education and opportunity. The Kelce Car Jam offers fun for all ages with a variety of food, drinks, and activities from our partners: Raising Cane’s Chicken Fingers, Travis Kelce’s Kitchen BBQ and Andy’s Frozen Custard. Attendees can choose between two ticket levels: General Admission or VIP. The VIP experience includes intimate access to an exclusive indoor space, complete with food and drinks. Tickets will go on sale starting Wednesday, September 4th and can be purchased at 87running.org. Don’t miss out on this unique opportunity to experience the magic of Kelce Car Jam, where the love for cars meets the heart of the community. Secure your tickets now and be part of a night to remember! About Eighty-Seven & Running The Eighty-Seven & Running Foundation is dedicated to empowering Kansas City's youth by providing vital resources and support to those who are undeserved and vulnerable. The foundation is committed to fostering community, encouraging personal growth, and paving a path to success for these young individuals. Contact Details Full Scope PR Team Travis Kelce tk@fullscopepr.com Eighty-Seven & Running Foundation Info info@87running.org Company Website https://87running.org/

September 04, 2024 07:00 AM Central Daylight Time

Article thumbnail News Release

NAVEX Announces 2024 Excellence Awards Finalists

NAVEX Global

NAVEX, a leading provider of integrated risk and compliance management software, announces today the 2024 NAVEX Excellence Awards finalists. Now in its fourth year, the awards celebrate organizations that demonstrate exceptional commitment to corporate governance, risk mitigation, and ethical practices. Each year, the NAVEX Excellence Awards highlight how robust governance, risk and compliance (GRC) programs can strengthen corporate culture and meaningfully impact business outcomes that matter. The 2024 finalists exemplify how effective GRC initiatives can proactively manage and mitigate risks when woven into the organizational fabric. "Congratulations to this year’s nominees and finalists for their outstanding achievements," said NAVEX Chief Customer Officer, Steve Chapman. "We are proud to partner with customers who are dedicated to advancing their GRC efforts. These awards shine a spotlight on some of the most innovative and effective programs in the industry, and we applaud the compliance teams at these companies for their ongoing efforts to build highly ethical, risk-aware organizations." The winners will be honored in several categories, including Ethics & Compliance, Risk Management, and Risk and Compliance Program of the Year. Selected from a highly competitive pool of nominations, this year’s finalists include: As in previous years, the judging panel brings together a mix of NAVEX leaders and seasoned GRC professionals. This year’s esteemed panel features: Barbara Boehler, Senior Director, Program on Corporate Compliance and Ethics, Fordham Law Bill Cameron, Founder and Principal, Cameron Advisory Services Carol Williams, CEO and Enterprise Risk Management Consultant, Strategic Decision Solutions Carrie Penman, Chief Risk and Compliance Officer, NAVEX Kyle Brasseur, Former Editor in Chief, Compliance Week Kyle Martin, Vice President of GRC Solutions, NAVEX Matt Kelly, Editor and CEO, Radical Compliance LLC Stephen Chapman, Chief Customer Officer, NAVEX Vera Cherepanova, Ethics Advocate, Consultant, Author, Studio Etica Award recipients will be announced after to the 2024 NAVEX Next Virtual Conference on October 1. NAVEX is trusted by thousands of customers worldwide to help them achieve the business outcomes that matter most. As the global leader in integrated risk and compliance management software and services, we deliver solutions through the NAVEX One platform, the industry’s most comprehensive governance, risk and compliance (GRC) information system. For more information, visit NAVEX.com and our blog. Follow us on Twitter and LinkedIn. Contact Details Navex Global +1 617-388-5773 scott.levesque@navex.com Company Website https://navex.com

September 03, 2024 08:06 AM Eastern Daylight Time

Article thumbnail News Release

Get Ready to Win Big—LHUNT Token Presale Now Live!

Spark Metro

The Crypto world never fails to amaze us in all new different ways. It has a new addition named LuckHunter with its ticker LHUNT. The presale of this LHUNT token is live, which is one of the game changing opportunities for the gamers and enthusiastic crypto investors. LuckHunter is an innovative online casino and gambling platform set to disrupt the online gambling industry. With a bag full of benefits, exclusively for the presale participants, don't wait and think much, grab the big opportunity now in this gaming industry. Exclusive Benefits for Early Adopters The LHUNT token is not just the regular crypto token, but it is a gateway to the world of rewards. The unique benefits it provides are as follows. 1. Up to 100% Worth of Presale Purchase Credits in Casino Imagine stepping into the world of Luckhunter.com with the presale purchase instantly transformed into casino credits. That’s right—participants in the LHUNT presale can receive up to 100% of their purchase value as casino credits, giving anyone a head start on the platform from day one. Whether being an experienced gambler or new to the scene, these credits allow gamblers to explore, play, and win big as soon as the platform goes live. 2. Huge Giveaways As a token of appreciation for your early support, presale.luckhunter.com is offering massive giveaways exclusively for presale participants. Expect a treasure trove of rewards, including crypto prizes, exclusive merchandise, and more. These giveaways aren’t just about luck—they’re designed to enhance user experience and keep the excitement going. 3. Staking Rewards The LHUNT presale isn’t just about buying tokens—it’s about investing in the future. Early participants will have access to enhanced staking rewards, allowing them to earn more LHUNT tokens simply by holding and staking their initial purchase. This is the only chance to maximize the investment while enjoying the perks of being an early adopter. 4. VIP Access Presale participants will be among the first to experience new games and features on Luckhunter.com. With VIP access, the buyers will have the inside track on the latest innovations, ensuring that they're always at the forefront of the gaming experience. This exclusive access is reserved only for those who believe in the platform from the start. 5. Exclusive Community Membership Joining the LHUNT presale means more than just buying tokens—it’s about becoming part of a community. Presale participants will gain access to a private community group where buyers can connect with like-minded individuals, share strategies, and engage directly with the Luckhunter.com team. This membership comes with special offers, insider information, and the chance to shape the future of the platform. A New Era in Crypto Gaming The LHUNT token presale represents more than just an investment—it’s the ticket to the next level of online gaming. By participating in this presale, investors not only secure their future in the crypto world but also gain access to a groundbreaking platform designed to reward its most loyal supporters. presale.luckhunter.com is set to redefine the casino and gambling experience, merging cutting-edge blockchain technology with the excitement of online gaming. Don’t miss this chance to be part of this revolution. The LHUNT token presale is live now, but it won’t last forever. Act Now—Secure Your LHUNT Tokens Today! This is your moment to step into the future of gaming. The LHUNT token presale is the chance to secure a piece of the action, enjoy unmatched benefits, and position yourself for massive rewards. Don’t wait—join the presale today and get ready to hunt for luck like never before. For more information and to participate in the LHUNT token presale, visit presale.luckhunter.com Or contact Telegram - https://t.me/LuckHunterCasino Twitter - https://x.com/LuckhuntrCasino Youtube - https://www.youtube.com/@LuckHunterCasino Email - team@luckhunter.com Contact Details Alex +1 302-497-6769 Apexreviews56@gmail.com

August 30, 2024 11:05 AM Eastern Daylight Time

Image
Article thumbnail News Release

Nuvectis Pharma Rises in Pre-Market Following FDA Orphan Drug Designation for NXP800, Fueling Optimism Ahead of Key Clinical Data

Global Markets News

Nuvectis Pharma (NASDAQ: NVCT) has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting Orphan Drug Designation for its lead candidate, NXP800. This designation, specifically for the treatment of ARID1a-deficient ovarian, fallopian tube, and primary peritoneal cancers, marks a critical step forward in Nuvectis’s mission to address unmet needs in oncology. Orphan Drug Designation: A Strategic Advantage The FDA’s Orphan Drug Designation is awarded to drugs that show promise in treating rare diseases affecting fewer than 200,000 people in the U.S. For Nuvectis, this designation not only validates the potential of NXP800 but also provides several strategic benefits. These include tax credits for clinical trial costs, exemption from certain FDA fees, and potentially seven years of market exclusivity upon approval. NXP800 targets ARID1a-deficient cancers, a subset of ovarian cancers that present significant treatment challenges. The Orphan Drug Designation underscores the importance of this candidate in potentially offering a new, more effective treatment option for patients with this specific genetic mutation. Background and Market Impact This latest achievement builds on Nuvectis Pharma’s earlier successes. Earlier this year, the FDA granted Fast Track Designation to NXP800 for its development in platinum-resistant, ARID1a-mutated ovarian cancer. The Fast Track status, combined with the Orphan Drug Designation, highlights the urgent need for innovative treatments in this space and positions NXP800 as a potential game-changer in oncology. Financial analysts have taken note of Nuvectis’s progress. H.C. Wainwright recently reiterated its buy rating for Nuvectis, setting a price target of $21. This optimistic outlook reflects the market’s confidence in the company’s strategic direction, particularly as it prepares to release key clinical data later this year. Anticipation for Upcoming Results The next few months are expected to be pivotal for Nuvectis Pharma. The company is poised to share updates from its ongoing Phase 1b clinical trial of NXP800, which targets patients with platinum-resistant, ARID1a-mutated ovarian cancer. This trial is being closely watched, as positive results could significantly advance the development of NXP800, bringing it closer to pivotal trials and eventual regulatory approval. Additionally, Nuvectis is also conducting a Phase 1a dose escalation study for NXP900, its second key candidate, which targets YES1/SRC-driven tumors. Updates from this study are expected to provide further insights into the safety and potential efficacy of NXP900. ### Nuvvectis' Full announcment, titled " Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA for NXP800 for the Treatment of ARID1a-deficient Ovarian, Fallopian Tube, and Primary Peritoneal Cancers" was published on August 29th, 2024. ### This article is for informational purposes only and is not intended to serve as financial, investment or any form of professional advice, recommendation or endorsement. Please review the full documentation detailing financial compensation disclosures and disclaimers the article is subject to. https://justpaste.it/fcm9n/pdf. Global Markets News Network is a commercial digital brand compensated to provide coverage of innovative companies and industries and it is thus subject to conflicts of interest. Contact Details Global Markets News News Coverage ronald@futuremarketsresearch.com

August 29, 2024 08:20 AM Eastern Daylight Time

1 ... 910111213 ... 412